The role of gene expression profiling in the clinical management of ovarian cancer
Open Access
- 30 November 2006
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 42 (17), 2930-2938
- https://doi.org/10.1016/j.ejca.2006.04.013
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experienceCancer, 2010
- Cancer of the OvaryNew England Journal of Medicine, 2004
- Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancerInternational Journal of Gynecologic Cancer, 2004
- Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)British Journal of Cancer, 2004
- Carcinoma of the ovaryInternational Journal of Gynecology & Obstetrics, 2003
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian CancerJAMA, 2000
- Clinical Significance of Apoptosis-Related Factors p53, Mdm2, and Bcl-2 in Advanced Ovarian CancerJournal of Clinical Oncology, 1999
- Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.Journal of Clinical Oncology, 1998
- Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.Journal of Clinical Pathology, 1994